Literature DB >> 22965776

Health-related quality of life in young adult patients with rheumatoid arthritis in Iran: reliability and validity of the Persian translation of the PedsQL™ 4.0 Generic Core Scales Young Adult Version.

Amir H Pakpour1, Isa Mohammadi Zeidi, Fariba Hashemi, Mohsen Saffari, Andrea Burri.   

Abstract

The objective of the present study was to determine the reliability and validity of the Persian translation of the Pediatric Quality of Life Inventory (PedsQL™) 4.0 Generic Core Scales Young Adult Version in an Iranian sample of young adult patients with rheumatoid arthritis (RA). One hundred ninety-seven young adult patients with RA completed the 23-item PedsQL™ and the 36-item Short-Form Health Survey (SF-36). Disease activity based on Disease Activity Score 28 was also measured. Internal consistency and test-retest reliability, as well as construct, discriminant, and convergent validity, were tested. Confirmatory factor analysis (CFA) was used to verify the original factor structure of the PedsQL™. Also, responsiveness to change in PedsQL™ scores over time was assessed. Cronbach's alpha coefficients ranged from α = 0.82 to α = 0.91. Test-retest reproducibility was satisfactory for all scales and the total scale score. The PedsQL proved good convergent validity with the SF-36. The PedsQL distinguished well between young adult patients and healthy young adults and also RA groups with different comorbidities. The CFA did not confirm the original four-factor model, instead, analyses revealed a best-fitting five-factor model for the PedsQL™ Young Adult Version. Repeated measures analysis of variance indicated that the PedsQL scale scores for young adults increased significantly over time. The Persian translation of the PedsQL™ 4.0 Generic Core Scales Young Adult Version demonstrated good psychometric properties in young adult patients with RA and can be recommended for the use in RA research in Iran.

Entities:  

Mesh:

Year:  2012        PMID: 22965776     DOI: 10.1007/s10067-012-2084-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  48 in total

1.  The intraclass correlation coefficient as a measure of reliability.

Authors:  J J Bartko
Journal:  Psychol Rep       Date:  1966-08

2.  Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.

Authors:  Vibeke Strand; Anne M Rentz; Mary A Cifaldi; Naijun Chen; Sanjoy Roy; Dennis Revicki
Journal:  J Rheumatol       Date:  2011-11-01       Impact factor: 4.666

3.  Baseline HAQ and SF-36 questionnaire scores cannot predict clinical remission, radiographic progression or the need for biological therapy in a three-year prospective study of a Brazilian early rheumatoid arthritis cohort.

Authors:  Licia Maria Henrique da Mota; Leopoldo Luiz Dos Santos Neto; Ana Cristina V Oliveira; Ivânio Alves Pereira; Rufus W Burlingame; Henri A Ménard; Ieda Maria Magalhães Laurindo
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

Review 4.  Juvenile rheumatoid arthritis: therapeutic perspectives.

Authors:  Ian C Chikanza
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module.

Authors:  James W Varni; Michael Seid; Tara Smith Knight; Tasha Burwinkle; Joy Brown; Ilona S Szer
Journal:  Arthritis Rheum       Date:  2002-03

6.  Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers.

Authors:  P L van Riel; A M van Gestel; L B van de Putte
Journal:  Br J Rheumatol       Date:  1996-09

7.  Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority.

Authors:  Turid Heiberg; Tore K Kvien
Journal:  Arthritis Rheum       Date:  2002-08

8.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

9.  Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey.

Authors:  F Salaffi; P Sarzi-Puttini; R Girolimetti; F Atzeni; S Gasparini; W Grassi
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

10.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

View more
  3 in total

1.  A comparison of children and adolescent's self-report and parental report of the PedsQL among those with and without autism spectrum disorder.

Authors:  M A Stokes; L Kornienko; A M Scheeren; H M Koot; S Begeer
Journal:  Qual Life Res       Date:  2016-12-22       Impact factor: 4.147

2.  Health-related quality of life in young adults in education, employment, or training: development of the Japanese version of Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales Young Adult Version.

Authors:  Mei Kaneko; Iori Sato; Takafumi Soejima; Kiyoko Kamibeppu
Journal:  Qual Life Res       Date:  2014-02-14       Impact factor: 4.147

3.  Predictors and effective factors on quality of life among Iranian patients with rheumatoid arthritis.

Authors:  Saied Karimi; Mohammad Hossein Yarmohammadian; Azad Shokri; Payman Mottaghi; Kamal Qolipour; Ayan Kordi; Najmeh Bahman Ziari
Journal:  Mater Sociomed       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.